Ignite Creation Date:
2025-12-25 @ 1:35 AM
Ignite Modification Date:
2026-03-02 @ 4:11 AM
Study NCT ID:
NCT00979394
Status:
TERMINATED
Last Update Posted:
2010-08-17
First Post:
2009-09-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Evaluation of Diabetes Care at Austrian GPs
Sponsor:
AstraZeneca
Organization:
Study Overview
Official Title:
Diabetes Care Austria 2009
Status:
TERMINATED
Status Verified Date:
2010-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
DCA09
Brief Summary:
This registery should show the medical care of patient with Type 2 Diabetes (T2D) at GP-offices. Furthermore data of co morbidities and risk factors should be evaluated. Objectives of this NIS (cross-sectional study) are:
* To evaluate which characteristics or co-morbidities are being existent for patient with T2D at GP level,
* To evaluate representative profile of patient with T2D in Austria,
* To evaluate which medical therapies are used.
* To evaluate which characteristics or co-morbidities are being existent for patient with T2D at GP level,
* To evaluate representative profile of patient with T2D in Austria,
* To evaluate which medical therapies are used.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: